Novo Holdings A/S 13D/13G Filings for Freeline Therapeutics Holdings plc (FRLN)

Novo Holdings A/S 13D and 13G filings for Freeline Therapeutics Holdings plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-11-02
4:32 pm
Sale
2021-11-0113GFreeline Therapeutics Holdings plc
FRLN
Novo Holdings A/S119,038
4.990%
-38,378decrease
(-24.38%)
Filing
2020-08-14
4:31 pm
Purchase
2020-08-1113GFreeline Therapeutics Holdings plc
FRLN
Novo Holdings A/S157,415
6.800%
157,415increase
(New Position)
Filing